STAT1 and acute myeloid leukemia: We further found that dasatinib-induced STAT1 activation was MEK/ERK cascade dependent since MEK inhibitors not only inhibited dasatinib-triggered phosphorylation of STAT1, but also abrogated dasatinib-induced differentiation of AML cells.